Why are there still so many breaches about claims?! Rina & Jean discuss why these may appear and why pushing the boundaries is important.
Trends from Q1 published PMCPA rulings show a staggering 96% allege poor standards - what does this mean and what can we do about this?
Sarah Hollywood from HollywoodMedico chats to Jean about ' bad blocker' signatories and provides tips on how 'good' signatories can give teams the competitive edge.
Patient Organisations often receive support from pharma companies BUT Case AUTH/3676/7/22 vs Roche helps us understand respective liabilities. Interested to learn the why, what and how? Come along to our Case Awareness Surgery on 2 May 2024 or ask us for the recording.
Three top tips from a good discussion about 2 cases and senior leader activities on social media - don't stop, challenge the PMCPA and appeals are worth it!! Case AUTH/3741/2/23 Case AUTH/3707/11/22
How to reduce confusion, encourage good record-keeping and stay complaint when briefing reps about call rates.
Sensational language, Mail article...yet no breach for GSK! Rina & Jean discuss why (Case AUTH/3691/9/22). A must listen for your comms team!
A LinkedIn poll recently confirmed that a compliance award could be based on bold ideas... Rina & Jean discuss why, what and how compliance can be celebrated alongside creativity. One for you and your agencies!
A recent case ruling (Case AUTH/3656/6/22) might leave you worried but we have three tips on how these interviews can be done well AND compliantly.
Our recent LinkedIn poll suggests 90% believe pharma's agencies should be Code-trained. Listen to our 3 top tips about the why, what and how representing best practice for ALL agencies.
Aargh with no definition of a promotional claim in the ABPI Code AND a terrible definition for a promotional aid, is it any wonder we are confused? Rina & Jean suggest a clear solution (after a little bit of moaning). See our comments and please send yours by 29 Feb 24, link here).
Rina & Jean discuss the proposed change in the 2024 Code for signatories requiring validation. Our top tips? Start PLANNING now, list out TASKS and COMMENT on the changes (see our comments and please send yours by 29 Feb 24, link here).
Rina & Jean reflect on all the great discussion from the Code Clarity Conference and what comments could be made on the upcoming PMCPA consultation.
Deaghlan O'Hagan joins Rina to discuss the why, who and what of anon complaints, covering 3 pain points and potential solutions.
Complaints about "garbage" need to be specific! Jean covers Case AUTH/3696/10/22 and why SOBI were ruled not in breach.
Sick of long e-sales aids that contain too much info about clinical trials? Is this less or more of a compliance risk? Listen as we suggest practical solutions.
Rina & Jean discuss some myths (please let us know if you think of others). We will be putting these to Alex Fell (Director, PMCPA) at our Annual Conference.
Rina & Jean cover the recent ruling in Case AUTH/3701/10/22 (Astellas v Janssen) and discuss pharma providing nurse support, patient support programmes and inducements to individuals.
How should we handle questions like this? Say no (there could be cake involved!!!)? Or say yes? Which questions should we be asking to be helpful, constructive and compliant?
Pharma feel nervous when engaging social media influencers, even though they can have a phenomenal impact. There's a lot to consider, so Rina & Jean chat through top-line principles so you can start gaining compliance confidence.